logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Institute for Pulmonary Diseases of Vojvodina

Source: Site record.
http://www.ipb-ild.edu.rs

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Institute for Pulmonary Diseases of Vojvodina (ipb-ild.edu.rs) is a specialized tertiary-care academic center dedicated to respiratory and pulmonary diseases, with strong relevance for clinical research in pulmonology, oncology, and infectious diseases. Located in Sremska Kamenica, the institute integrates clinical care, education, and scientific research, supported by multiple specialized clinics including obstructive lung diseases, interstitial and granulomatous diseases, pulmonary oncology, thoracic surgery, and emergency pulmonology.

Source: Trial-derived.
42Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
13Active Trials
Source: Trial-derived.
22Completed Trials
Source: Trial-derived.
52Unique Conditions
Source: Trial-derived.
31Unique Sponsors

Conditions

Source: Trial-derived. Pulmonary Arterial Hypertension (6)Source: Trial-derived. Small Cell Lung Cancer (5)Source: Trial-derived. Non-Small Cell Lung Cancer (4)Source: Trial-derived. Cardiovascular Diseases (2)Source: Trial-derived. Connective Tissue Diseases (2)Source: Trial-derived. Familial Primary Pulmonary Hypertension (2)Source: Trial-derived. Hypertension (2)Source: Trial-derived. Hypertension, Pulmonary (2)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (6)Source: Trial-derived. AbbVie (4)Source: Trial-derived. Actelion (2)Source: Trial-derived. Amgen (2)Source: Trial-derived. Boehringer Ingelheim (2)Source: Trial-derived. Chiesi Farmaceutici S.p.A. (2)Source: Trial-derived. Connect Biopharm LLC (2)Source: Trial-derived. Incyte Corporation (2)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Full pulmonary function lab (DLCO / plethysmography)
Source: AI-inferred. Six-minute walk test

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Histology / pathology

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Brain imaging